Type of Action: RIA
Duration: 36 months
Start Date: 1 October 2015
Grant Agreement Nr: 676550
Web: BBMRI-ERIC website
Coordinator: Erik Steinfelder
Total requested Grant by Consortium: €4,950,860.00
Total requested Grant by BBMRI-ERIC: €3,786,840.00
(includes funds for Headquarters, Common Service ELSI, Common Service IT, linked third parties)
Linked Third Parties/BBMRI-ERIC Framework Agreement:
BBMRI.at/MUG; BBMRI.fi/THL; BBMRI.mt/UoM; BBMRI.it/UNIMIB
Benefit/tasks for BBMRI-ERIC: Coordinated by BBMRI-ERIC, funding for key activities
The ADOPT BBMRI-ERIC proposal aims at boosting and accelerating implementation of BBMRI-ERIC and its services. Its main deliverables are designed to complete or launch the construction of key Common Services of the Research Infrastructure as required for European Strategy Forum on Research Infrastructure-(ESFRI) -projects ‘under implementation’, reflecting the targets of the European Research Area (ERA). One of the challenges in the post-genomic era is the research on common complex diseases, such as cancer, diabetes and Alzheimer’s disease. Revealing these diseases will depend critically on the study of human biological samples and data from large numbers of patients and healthy individuals. The EU’s ageing population will result in an increase in many of those diseases and consequently an increased healthcare expenditure for senior citizens. Its implementation is essential for the understanding of the diversity of human diseases, biological samples and corresponding data, which are required for the development of any new drug or diagnostic assay and are, therefore, critical for the advancement in health research, ultimately leading to personalised medicine. BBMRI-ERIC will provide a gateway access to the collections of the European research community, expertise and services building on the outcome of ADOPT BBMRI-ERIC.
BBMRI-ERIC incl. linked third parties/(namely MUG on behalf of BBMRI.at, THL on behalf of BBMRI.fi, UoM on behalf of BBMRI.mt, UNIMIB on behalf of BBMRI.it), BELSPO on behalf of BBMRI.be, Belgium; SNF on behalf of BBMRI.ch, Switzerland; MMCI on behalf of BBMRI.cz, Czech Republic; Charité on behalf of BBMRI.de, Germany; UT on behalf of BBMRI.ee, Estonia; INSERM on behalf of BBMRI.fr, France; AA on behalf of BBMRI.gr, Greece; LUMC on behalf of BBMRI.nl, The Netherlands; NTNU on behalf of BBMRI.no, Norway; Kierujący Biobankiem Wrocławskiego Centrum; Badań EIT on behalf of BBMRI.pl, Poland; KI on behalf of BBMRI.se, Sweden; Dokuz Eylul University on behalf of BBMRI.tr, Turkey; IARC, France; TUM, Germany; IOR, Italy, University College London, United Kingdom
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 676550.